1. Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System. (March 2019) Authors: Naganuma, Misa; Tahara, Kohei; Hasegawa, Shiori; Fukuda, Akiho; Sasaoka, Sayaka; Hatahira, Haruna; Motooka, Yumi; Nakao, Satoshi; Mukai, Ririka; Hirade, Kouseki; Yoshimura, Tomoaki; Kato, Takeshi; Takeuchi, Hirofumi; Nakamura, Mitsuhiro Journal: SAGE open medicine Issue: Volume 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database. (26th April 2018) Authors: Naganuma, Misa; Motooka, Yumi; Sasaoka, Sayaka; Hatahira, Haruna; Hasegawa, Shiori; Fukuda, Akiho; Nakao, Satoshi; Shimada, Kazuyo; Hirade, Koseki; Mori, Takayuki; Yoshimura, Tomoaki; Kato, Takeshi; Nakamura, Mitsuhiro Journal: SAGE open medicine Issue: Volume 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of drug-induced hand–foot syndrome using a spontaneous reporting system database. (May 2022) Authors: Yoshida, Yu; Sasaoka, Sayaka; Tanaka, Mizuki; Matsumoto, Kiyoka; Inoue, Misaki; Satake, Riko; Shimada, Kazuyo; Mukai, Ririka; Suzuki, Takaaki; Iwata, Mari; Goto, Fumiya; Mori, Takayuki; Mori, Koki; Yoshimura, Tomoaki; Nakamura, Mitsuhiro Journal: Therapeutic advances in drug safety Issue: Volume 13(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Analysis of pharmacological interventions among hospitalised patients with COVID‑19: A focus on severe cases. Issue 2 (2023) Authors: Shinoda, Yasutaka; Ohashi, Kengo; Matsuoka, Tomoko; Yoshimura, Tomoaki Journal: Biomedical reports Issue: Volume 18:Issue 2(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cost-effectiveness and safety of ramucirumab plus paclitaxel chemotherapy in the treatment of advanced and recurrent gastric cancer. (September 2018) Authors: Kimura, Michio; Usami, Eiseki; Teramachi, Hitomi; Yoshimura, Tomoaki Journal: Journal of oncology pharmacy practice Issue: Volume 24:Number 6(2018) Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and Safety of Daikenchuto for Constipation and Dose-Dependent Differences in Clinical Effects. (5th March 2018) Authors: Hirose, Tatsuya; Shinoda, Yasutaka; Kuroda, Ayaka; Yoshida, Aya; Mitsuoka, Machiko; Mori, Kouki; Kawachi, Yuki; Moriya, Akihiro; Tanaka, Kouji; Takeda, Atsuko; Yoshimura, Tomoaki; Sugiyama, Tadashi Other Names: Zorena Katarzyna Academic Editor. Journal: International journal of chronic diseases Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents. (September 2017) Authors: Kimura, Michio; Go, Makiko; Iwai, Mina; Usami, Eiseki; Teramachi, Hitomi; Yoshimura, Tomoaki Journal: Journal of oncology pharmacy practice Issue: Volume 23:Number 6(2017) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evaluation of treatment outcomes of patients with MRSA bacteremia following antimicrobial stewardship programs with pharmacist intervention. Issue 3 (8th February 2018) Authors: Ohashi, Kengo; Matsuoka, Tomoko; Shinoda, Yasutaka; Fukami, Yasuyuki; Shindoh, Joe; Yagi, Tetsuya; Yoshimura, Tomoaki; Sugiyama, Tadashi Journal: International journal of clinical practice Issue: Volume 72:Issue 3(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Influence of renal dysfunction on dose reduction and virologic efficacy of regimens combining ribavirin and all‐oral direct acting antivirals in patients with chronic hepatitis C virus infection. Issue 5 (7th February 2019) Authors: Nakashima, Megumi; Toyoda, Hidenori; Tada, Toshifumi; Mizuno, Kazuyuki; Iio, Etsuko; Tanaka, Yasuhito; Sugiyama, Tadashi; Yoshimura, Tomoaki; Kumada, Takashi Journal: Hepatology research Issue: Volume 49:Issue 5(2019) Page Start: 512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmaceutical Care for Patients Undergoing S-1 Plus Cisplatin Therapy for Unresectable Recurrent Gastric Cancer. (August 2013) Authors: Kimura, Michio; Usami, Eiseki; Yoshimura, Tomoaki; Yasuda, Tadashi; Kaneoka, Yuji; Teramachi, Hitomi; Sugiyama, Tadashi; Tsuchiya, Teruo Journal: Journal of pharmacy practice Issue: Volume 26:Number 4(2013) Page Start: 409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗